| Name | Title | Contact Details |
|---|
BioSig Technologies, Inc. (NASDAQ: BSGM) is a medical device company that is developing a proprietary biomedical signal processing technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP™System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig aims to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP™ System is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and has received FDA 510(k) clearance for the PURE EP™ System in August 2018. BioSig Technologies, Inc. is a Nasdaq company: NASDAQ:BSGM.
Humanscale is the premier designer and manufacturer of sustainable, high-performance ergonomic products for the workplace. Our award-winning solutions improve the health, efficiency and quality of work life. Since its founding in 1983, Humanscale has held the belief that design based on functionality and ease of use results in honest and enduring forms. Humanscale`s simple, elegant solutions stand the test of time—both functionally and aesthetically—while consuming as little of the Earth`s limited resources as possible. Nearly every Humanscale product can contribute to the achievement of LEED-CI, -NC and -EB credits. In addition to manufacturing premier ergonomic work tools, Humanscale`s team of certified ergonomists is available to help organizations further improve worker comfort, reduce injuries, and boost productivity through ergonomic assessments, training, and program development. With headquarters in New York City, Humanscale`s showrooms, offices and manufacturing facilities are strategically located throughout North America, Europe, Asia and Australia, while a worldwide network of esteemed distributors enables Humanscale solutions to reach every corner of the globe.
Edwards Lifesciences (NYSE: EW) is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that save and enhance lives. Headquartered in Irvine, California, Edwards Lifesciences has extensive operations in North America, Europe, Japan, Latin America and Asia and currently employs 11,000+ individuals worldwide. For us, helping patients is not a slogan ¬ it`s our life¹s work. From developing devices that replace or repair a diseased heart valve to creating new technologies that monitor vital signs in the critical care setting, we help ensure that patients regain and even improve their quality of life. Joining Edwards Lifesciences means innovating, pushing boundaries and being creative while always putting patients first. It means solving challenges with colleagues who share your sense of urgency, optimism, and enthusiasm, colleagues who are just as focused on testing their limits and taking ownership. And it means that you will be empowered to get the job done by taking charge of your work, your health, and your career.
Avinger, Inc. is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems for the treatment of patients with peripheral artery disease (PAD). PAD is characterized by a build-up of plaque in the arteries that supply blood to the arms and legs. The company’s mission is to radically change the way vascular disease is treated through the introduction of products based on its lumivascular platform, the only intravascular image-guided system of therapeutic catheters available in this market. Avinger’s current lumivascular products include the Lightbox imaging console, the Ocelot family of catheters, which are designed to penetrate total arterial blockages, known as chronic total occlusions, or CTOs, and Pantheris, the first-ever image- guided atherectomy device, designed to precisely remove arterial plaque in PAD patients.
Direct Action Medical Network is a Alexandria, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.